GGrantIndex
Sort

40,608 grants matching prostate cancer

Protein kinase C and lung carcinogenesis

$391,197
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2016 · ES

Protein kinase C and lung carcinogenesis

$391,197
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2017 · ES

Protein kinase C and lung carcinogenesis

$391,197
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2015 · ES

Co-targeting IGF-1R and Glutaminase in Ewing Sarcoma

$391,186
Hamid Band · University Of Nebraska Medical Center · R21 · FY2025 · CA

Structure and Function of Kinase Family Receptors Regulating Translation

$391,147
Alexei Korennykh · Princeton University · R01 · FY2020 · GM

Adipocyte regulation of tumor survival in metastatic prostate cancer: new targets for therapy

$391,135
Izabela Podgorski · Wayne State University · R01 · FY2023 · CA

Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance

$391,109
Antonio Fojo · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

IS LACTATE DEHYDROGENASE-A (LDH-A) A VIABLE TARGET FOR PROSTATE CANCER THERAPY?

$391,109
Beth Israel Deaconess Medical Center, Inc. · · FY2010 · Department of Defense

Glycoprotein Biomarkers for Early Detection of Aggressive Prostate Cancer

$391,040
Hui Zhang · Johns Hopkins University · U01 · FY2021 · CA

The Role of YY1 in Castration-Resistant Prostate Cancer

$391,033
Ling Cai · Duke University · R01 · FY2024 · CA

The B7x pathways in the tumor microenvironment

$391,020
Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2023 · CA

The B7x pathways in the tumor microenvironment

$391,020
Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2022 · CA

Translational Research in Cancer

$391,000
Karen E Knudsen · Thomas Jefferson University · P30 · FY2020 · CA

ADMINISTRATIVE CORE

$390,997
Cimona V Hinton · Clark Atlanta University · U54 · FY2025 · MD

BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS

$390,982
Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2012 · CA

PHARMACOGENETICS OF DRUG AND CARCINOGEN METABOLISM

$390,972
University Of Louisville · R01 · FY2001 · CA

Therapy-induced cognitive impairment in a rat model of prostate cancer

$390,969
David A Morilak · University Of Texas Hlth Science Center · R01 · FY2024 · CA

Novel 3-dimensional (3-D) platform for high-throughput glycomics analysis

$390,968
Jian Zhang · Ada Technologies, Inc. · R44 · FY2010 · RR

Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition

$390,963
Joshi James Alumkal · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

MORTALITY FOLLOW-UP AND ANALYSES OF MEN IN THE MRFIT

$390,960
University Of Minnesota Twin Cities · R01 · FY2005 · HL

Geostatistical software for the space-time analysis of health disparities

$390,905
Pierre E Goovaerts · Biomedware · R44 · FY2007 · CA

Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition

$390,879
Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2020 · CA

Eastern Cooperative Oncology Group

$390,865
David H Johnson · Vanderbilt University · U10 · FY2008 · CA

The Biology of Prostate Stem Cells

$390,864
E Lynette Wilson · New York University School Of Medicine · R01 · FY2008 · CA

Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening

$390,841
Louise Henderson · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA